No retraction, correction or concern found when last checked on Oct 31, 2026.

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

Katharina Röltgen, Abigail E. Powell, Oliver F. Wirz and 27 more

Science Immunology · 2020

Abstract

Illness severity in COVID-19 correlates with specificity of serological responses, but antibody levels decrease in most patients.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 50

1.
A pneumonia outbreak associated with a new coronavirus of probable bat origin · 2020
No notice
2.
Z. Wu, J. M. McGoogan, Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 323, 1239–1242 (2020 ).
Not in our library10.1001/jama.2020.2648
3.
C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Z. Cheng, T. Yu, J. Xia, Y. Wei, W. Wu, X. Xie, W. Yin, H. Li, M. Liu, Y. Xiao, H. Gao, L. Guo, J. Xie, G. Wang, R. Jiang, Z. Gao, Q. Jin, J. Wang, B. Cao, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020 ).
Not in our library10.1016/s0140-6736(20)30183-5
4.
N. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han, Y. Qiu, J. Wang, Y. Liu, Y. Wei, J. Xia, T. Yu, X. Zhang, L. Zhang, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 395, 507–513 (2020 ).
Not in our library10.1016/s0140-6736(20)30211-7
5.
F. Zhou, T. Yu, R. Du, G. Fan, Y. Liu, Z. Liu, J. Xiang, Y. Wang, B. Song, X. Gu, L. Guan, Y. Wei, H. Li, X. Wu, J. Xu, S. Tu, Y. Zhang, H. Chen, B. Cao, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395, 1054–1062 (2020 ).
Not in our library10.1016/s0140-6736(20)30566-3
6.
S. Richardson, J. S. Hirsch, M. Narasimhan, J. M. Crawford, T. McGinn, K. W. Davidson, D. P. Barnaby, L. B. Becker, J. D. Chelico, S. L. Cohen, J. Cookingham, K. Coppa, M. A. Diefenbach, A. J. Dominello, J. Duer-Hefele, L. Falzon, J. Gitlin, N. Hajizadeh, T. G. Harvin, D. A. Hirschwerk, E. J. Kim, Z. M. Kozel, L. M. Marrast, J. N. Mogavero, G. A. Osorio, M. Qiu, T. P. Zanos; the Northwell COVID-19 Research Consortium, Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 323, 2052–2059 (2020 ).
Not in our library10.1001/jama.2020.6775
7.
T. Chen, D. Wu, H. Chen, W. Yan, D. Yang, G. Chen, K. Ma, D. Xu, H. Yu, H. Wang, T. Wang, W. Guo, J. Chen, C. Ding, X. Zhang, J. Huang, M. Han, S. Li, X. Luo, J. Zhao, Q. Ning, Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ 368, m1091 (2020 ).
Not in our library10.1136/bmj.m1091
8.
J. Perez-Saez, S. A. Lauer, L. Kaiser, S. Regard, E. Delaporte, I. Guessous, S. Stringhini, A. S. Azman; Serocov-POP Study Group, Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect. Dis. 0, S1473-3099(20)30584-3 (2020 ).
Not in our library10.1016/s1473-3099(20)30584-3
9.
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 · 2020
No notice
10.
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine · 2020
No notice
11.
F. Li, Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu. Rev. Virol. 3, 237–261 (2016 ).
Not in our library10.1146/annurev-virology-110615-042301
12.
B. Ju, Q. Zhang, J. Ge, R. Wang, J. Sun, X. Ge, J. Yu, S. Shan, B. Zhou, S. Song, X. Tang, J. Yu, J. Lan, J. Yuan, H. Wang, J. Zhao, S. Zhang, Y. Wang, X. Shi, L. Liu, J. Zhao, X. Wang, Z. Zhang, L. Zhang, Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584, 115–119 (2020 ).
Not in our library10.1038/s41586-020-2380-z
13.
M. Ho, Perspectives on the development of neutralizing antibodies against SARS-CoV-2. Antibody Ther 3, 109–114 (2020 ).
Not in our library10.1093/abt/tbaa009
14.
F. J. Ibarrondo, J. A. Fulcher, D. Goodman-Meza, J. Elliott, C. Hofmann, M. A. Hausner, K. G. Ferbas, N. H. Tobin, G. M. Aldrovandi, O. O. Yang, Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19. N. Engl. J. Med. 383, 1085–1087 (2020 ).
Not in our library10.1056/nejmc2025179
15.
Q.-X. Long, X.-J. Tang, Q.-L. Shi, Q. Li, H.-J. Deng, J. Yuan, J.-L. Hu, W. Xu, Y. Zhang, F.-J. Lv, K. Su, F. Zhang, J. Gong, B. Wu, X.-M. Liu, J.-J. Li, J.-F. Qiu, J. Chen, A.-L. Huang, Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 26, 1200–1204 (2020 ).
Not in our library10.1038/s41591-020-0965-6
16.
D. F. Gudbjartsson, G. L. Norddahl, P. Melsted, K. Gunnarsdottir, H. Holm, E. Eythorsson, A. O. Arnthorsson, D. Helgason, K. Bjarnadottir, R. F. Ingvarsson, B. Thorsteinsdottir, S. Kristjansdottir, K. Birgisdottir, A. M. Kristinsdottir, M. I. Sigurdsson, G. A. Arnadottir, E. V. Ivarsdottir, M. Andresdottir, F. Jonsson, A. B. Agustsdottir, J. Berglund, B. Eiriksdottir, R. Fridriksdottir, E. E. Gardarsdottir, M. Gottfredsson, O. S. Gretarsdottir, S. Gudmundsdottir, K. R. Gudmundsson, T. R. Gunnarsdottir, A. Gylfason, A. Helgason, B. O. Jensson, A. Jonasdottir, H. Jonsson, T. Kristjansson, K. G. Kristinsson, D. N. Magnusdottir, O. T. Magnusson, L. B. Olafsdottir, S. Rognvaldsson, L. le Roux, G. Sigmundsdottir, A. Sigurdsson, G. Sveinbjornsson, K. E. Sveinsdottir, M. Sveinsdottir, E. A. Thorarensen, B. Thorbjornsson, M. Thordardottir, J. Saemundsdottir, S. H. Kristjansson, K. S. Josefsdottir, G. Masson, G. Georgsson, M. Kristjansson, A. Moller, R. Palsson, T. Gudnason, U. Thorsteinsdottir, I. Jonsdottir, P. Sulem, K. Stefansson, Humoral Immune Response to SARS-CoV-2 in Iceland. N. Engl. J. Med. 383, 1724–1734 (2020 ).
Not in our library10.1056/nejmoa2026116
17.
Y. Wang, L. Zhang, L. Sang, F. Ye, S. Ruan, B. Zhong, T. Song, A. N. Alshukairi, R. Chen, Z. Zhang, M. Gan, A. Zhu, Y. Huang, L. Luo, C. K. P. Mok, M. M. Al Gethamy, H. Tan, Z. Li, X. Huang, F. Li, J. Sun, Y. Zhang, L. Wen, Y. Li, Z. Chen, Z. Zhuang, J. Zhuo, C. Chen, L. Kuang, J. Wang, H. Lv, Y. Jiang, M. Li, Y. Lin, Y. Deng, L. Tang, J. Liang, J. Huang, S. Perlman, N. Zhong, J. Zhao, J. S. Malik Peiris, Y. Li, J. Zhao, Kinetics of viral load and antibody response in relation to COVID-19 severity. J. Clin. Invest. 130, 5235–5244 (2020 ).
Not in our library10.1172/jci138759
18.
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients · 2020
No notice
19.
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival · 2020
No notice
20.
DNA vaccine protection against SARS-CoV-2 in rhesus macaques · 2020
No notice
21.
N. M. A. Okba, V. S. Raj, I. Widjaja, C. H. GeurtsvanKessel, E. de Bruin, F. D. Chandler, W. B. Park, N.-J. Kim, E. A. B. A. Farag, M. Al-Hajri, B.-J. Bosch, M. D. Oh, M. P. G. Koopmans, C. B. E. M. Reusken, B. L. Haagmans, Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections. Emerg. Infect. Dis. 25, 1868–1877 (2019 ).
Not in our library10.3201/eid2510.190051
22.
Antibody Response and Disease Severity in Healthcare Worker MERS Survivors · 2016
No notice
23.
C. Drosten, B. Meyer, M. A. Müller, V. M. Corman, M. Al-Masri, R. Hossain, H. Madani, A. Sieberg, B. J. Bosch, E. Lattwein, R. F. Alhakeem, A. M. Assiri, W. Hajomar, A. M. Albarrak, J. A. Al-Tawfiq, A. I. Zumla, Z. A. Memish, Transmission of MERS-coronavirus in household contacts. N. Engl. J. Med. 371, 828–835 (2014 ).
Not in our library10.1056/nejmoa1405858
24.
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 · 2020
No notice
25.
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody · 2020
No notice
26.
D. Wrapp, N. Wang, K. S. Corbett, J. A. Goldsmith, C.-L. Hsieh, O. Abiona, B. S. Graham, J. S. McLellan, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260–1263 (2020 ).
Not in our library10.1126/science.abb2507
27.
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays · 2020
No notice
28.
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model · 2020
No notice
29.
D. P. Oran, E. J. Topol, Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review. Ann. Intern. Med. 173, 362–367 (2020 ).
Not in our library10.7326/m20-3012
30.
CDC, Coronavirus Disease 2019 (COVID-19) – SymptomsCenters for Disease Control and Prevention (2020) (available at https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html).
Not in our library
31.
C. A. Hogan, B. A. Stevens, M. K. Sahoo, C. Huang, N. Garamani, S. Gombar, F. Yamamoto, K. Murugesan, J. Kurzer, J. Zehnder, B. A. Pinsky, High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease. Clin. Infect. Dis. ciaa1054 (2020 ).
Not in our library10.1093/cid/ciaa1054
32.
Q.-X. Long, B.-Z. Liu, H.-J. Deng, G.-C. Wu, K. Deng, Y.-K. Chen, P. Liao, J.-F. Qiu, Y. Lin, X.-F. Cai, D.-Q. Wang, Y. Hu, J.-H. Ren, N. Tang, Y.-Y. Xu, L.-H. Yu, Z. Mo, F. Gong, X.-L. Zhang, W.-G. Tian, L. Hu, X.-X. Zhang, J.-L. Xiang, H.-X. Du, H.-W. Liu, C.-H. Lang, X.-H. Luo, S.-B. Wu, X.-P. Cui, Z. Zhou, M.-M. Zhu, J. Wang, C.-J. Xue, X.-F. Li, L. Wang, Z.-J. Li, K. Wang, C.-C. Niu, Q.-J. Yang, X.-J. Tang, Y. Zhang, X.-M. Liu, J.-J. Li, D.-C. Zhang, F. Zhang, P. Liu, J. Yuan, Q. Li, J.-L. Hu, J. Chen, A.-L. Huang, Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 26, 845–848 (2020 ).
Not in our library10.1038/s41591-020-0897-1
33.
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients · 2020
No notice
34.
L. F. Westblade, G. Brar, L. C. Pinheiro, D. Paidoussis, M. Rajan, P. Martin, P. Goyal, J. L. Sepulveda, L. Zhang, G. George, D. Liu, S. Whittier, M. Plate, C. B. Small, J. H. Rand, M. M. Cushing, T. J. Walsh, J. Cooke, M. M. Safford, M. Loda, M. J. Satlin, SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19. Cancer Cell 38, 661–671.e2 (2020 ).
Not in our library10.1016/j.ccell.2020.09.007
35.
R. Magleby, L. F. Westblade, A. Trzebucki, M. S. Simon, M. Rajan, J. Park, P. Goyal, M. M. Safford, M. J. Satlin, Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019. Nephrol. Dial. Transplant. ciaa851 (2020 ).
Not in our library10.1093/cid/ciaa851
36.
A. Casadevall, L. A. Pirofski, The convalescent sera option for containing COVID-19. J. Clin. Invest. 130, 1545–1548 (2020 ).
Not in our library10.1172/jci138003
37.
J. D. Goldman, K. Wang, K. Roltgen, S. C. A. Nielsen, J. C. Roach, S. N. Naccache, F. Yang, O. F. Wirz, K. E. Yost, J.-Y. Lee, K. Chun, T. Wrin, C. J. Petropoulos, I. Lee, S. Fallen, P. M. Manner, J. A. Wallick, H. A. Algren, K. M. Murray, Y. Su, J. Hadlock, J. Jeharajah, W. R. Berrington, G. P. Pappas, S. T. Nyatsatsang, A. L. Greninger, A. T. Satpathy, J. S. Pauk, S. D. Boyd, J. R. Heath, Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: A case report. medRxiv 2020.09.22.20192443 (2020 ).
Not in our library10.1101/2020.09.22.20192443
38.
K. K.-W. To, I. F.-N. Hung, J. D. Ip, A. W.-H. Chu, W.-M. Chan, A. R. Tam, C. H.-Y. Fong, S. Yuan, H.-W. Tsoi, A. C.-K. Ng, L. L.-Y. Lee, P. Wan, E. Tso, W.-K. To, D. Tsang, K.-H. Chan, J.-D. Huang, K.-H. Kok, V. C.-C. Cheng, K.-Y. Yuen, COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Nephrol. Dial. Transplant. ciaa1275 (2020 ).
Not in our library10.1093/cid/ciaa1275
39.
C. Cervia, J. Nilsson, Y. Zurbuchen, A. Valaperti, J. Schreiner, A. Wolfensberger, M. E. Raeber, S. Adamo, S. Weigang, M. Emmenegger, S. Hasler, P. P. Bosshard, E. De Cecco, E. Bächli, A. Rudiger, M. Stüssi-Helbling, L. C. Huber, A. S. Zinkernagel, D. J. Schaer, A. Aguzzi, G. Kochs, U. Held, E. Probst-Müller, S. K. Rampini, O. Boyman, Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J. Allergy Clin. Immunol. S0091-6749(20)31623-7 (2020 ).
Not in our library10.1016/j.jaci.2020.10.040
40.
A. W. D. Edridge, J. Kaczorowska, A. C. R. Hoste, M. Bakker, M. Klein, K. Loens, M. F. Jebbink, A. Matser, C. M. Kinsella, P. Rueda, M. Ieven, H. Goossens, M. Prins, P. Sastre, M. Deijs, L. van der Hoek, Seasonal coronavirus protective immunity is short-lasting. Nat. Med. 26, 1691–1693 (2020 ).
Not in our library10.1038/s41591-020-1083-1

All 50 references

Cited by papers we hold 11

Genetic variation in the immunoglobulin heavy chain locus shapes the human antibody repertoire · 2023
No notice
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination · 2022
No notice
Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis · 2022
Not checked
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization · 2022
Not checked
High-Throughput Multiplex SARS-CoV-2 IgG Microsphere Immunoassay for Dried Blood Spots: A Public Health Strategy for Enhanced Serosurvey Capacity · 2021
Not checked
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection · 2021
No notice
Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study · 2021
Not checked
Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain · 2021
Not checked
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice · 2021
No notice
Immunity to SARS‐CoV‐2 induced by infection or vaccination · 2021
No notice
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection · 2021
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.